Unknown

Dataset Information

0

Soluble epoxide hydrolase dimerization is required for hydrolase activity.


ABSTRACT: Soluble epoxide hydrolase (sEH) plays a key role in the metabolic conversion of the protective eicosanoid 14,15-epoxyeicosatrienoic acid to 14,15-dihydroxyeicosatrienoic acid. Accordingly, inhibition of sEH hydrolase activity has been shown to be beneficial in multiple models of cardiovascular diseases, thus identifying sEH as a valuable therapeutic target. Recently, a common human polymorphism (R287Q) was identified that reduces sEH hydrolase activity and is localized to the dimerization interface of the protein, suggesting a relationship between sEH dimerization and activity. To directly test the hypothesis that dimerization is essential for the proper function of sEH, we generated mutations within the sEH protein that would either disrupt or stabilize dimerization. We quantified the dimerization state of each mutant using a split firefly luciferase protein fragment-assisted complementation system. The hydrolase activity of each mutant was determined using a fluorescence-based substrate conversion assay. We found that mutations that disrupted dimerization also eliminated hydrolase enzymatic activity. In contrast, a mutation that stabilized dimerization restored hydrolase activity. Finally, we investigated the kinetics of sEH dimerization and found that the human R287Q polymorphism was metastable and capable of swapping dimer partners faster than the WT enzyme. These results indicate that dimerization is required for sEH hydrolase activity. Disrupting sEH dimerization may therefore serve as a novel therapeutic strategy for reducing sEH hydrolase activity.

SUBMITTER: Nelson JW 

PROVIDER: S-EPMC3597810 | biostudies-literature | 2013 Mar

REPOSITORIES: biostudies-literature

altmetric image

Publications

Soluble epoxide hydrolase dimerization is required for hydrolase activity.

Nelson Jonathan W JW   Subrahmanyan Rishi M RM   Summers Sol A SA   Xiao Xiangshu X   Alkayed Nabil J NJ  

The Journal of biological chemistry 20130128 11


Soluble epoxide hydrolase (sEH) plays a key role in the metabolic conversion of the protective eicosanoid 14,15-epoxyeicosatrienoic acid to 14,15-dihydroxyeicosatrienoic acid. Accordingly, inhibition of sEH hydrolase activity has been shown to be beneficial in multiple models of cardiovascular diseases, thus identifying sEH as a valuable therapeutic target. Recently, a common human polymorphism (R287Q) was identified that reduces sEH hydrolase activity and is localized to the dimerization interf  ...[more]

Similar Datasets

| S-EPMC2533064 | biostudies-literature
| S-EPMC6331899 | biostudies-literature
| S-EPMC7237305 | biostudies-literature
| S-EPMC6151598 | biostudies-literature
| S-EPMC2596069 | biostudies-literature
| S-EPMC6442743 | biostudies-literature
| S-EPMC3284163 | biostudies-literature
| S-EPMC5580818 | biostudies-literature
| S-EPMC3313618 | biostudies-literature
| S-EPMC3517215 | biostudies-literature